New drug aims to stop itchy eyes from birch pollen
NCT ID NCT06602739
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tested two experimental drugs, REGN5713 and REGN5715, given together to reduce eye allergy symptoms caused by birch pollen. 54 adults with a history of moderate to severe birch pollen allergy received either the drug or a placebo. The main goal was to see if the drug could lower eye itching and redness during a controlled allergen challenge.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
-
Clinique de Specialisee en Allergie de la Capitale
Québec, G1V 4W2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
Conditions
Explore the condition pages connected to this study.